What does it take to build a successful MedTech startup? It’s a multi-million dollar question and the answer involves strong execution of a highly strategic plan.
In this episode of the Global Medical Device Podcast, Jon Speer talks to Duane Mancini, president and founder of Project Medtech, and host of the Project Medtech Podcast.
Listen as Jon and Duane talk about building a startup in the MedTech industry and why it’s so important for MedTech startups to be strategic in their approach to bringing a device to market, like taking advantage of reimbursement opportunities and leveraging a QMS to support all efforts along the way.
Like this episode? Subscribe today on iTunes or Spotify.
Project Medtech Podcast - Founder and President of AmSpirit Business Connections
Mike Drues of Vascular Sciences
Global Medical Device Podcast - What are the Strategic Priorities for CDRH in 2021?
Greenlight Guru YouTube Channel
MedTech True Quality Stories Podcast
“People go into the medical device industry to save lives. There has to be a business aspect of it. It is what it is. Investors want to know that.”
“Not knowing your reimbursement plan is really risky because it can change your regulatory plan.”
“Startups need to get to market as efficiently and in the least amount of time as possible to reduce the amount of capital that they have to spend.”
“Your easiest path to market from a regulatory standpoint, isn’t always your best path to market in general for your business.”
The Global Medical Device Podcast powered by Greenlight Guru is where today's brightest minds in the medical device industry go to get their most useful and actionable insider knowledge, direct from some of the world's leading medical device experts and companies.
Nick Tippmann is an experienced marketing professional lauded by colleagues, peers, and medical device professionals alike for his strategic contributions to Greenlight Guru from the time of the company’s inception. Previous to Greenlight Guru, he co-founded and led a media and event production company that was later...